LAS INFECCIONES DE TRANSMISIÓN SEXUAL. - Euskadi.net

hea- and chlamydia-associated acute
pelvic inflammatory disease. A 25-year
study from an urban area of central Sweden.
Sex Transm Dis 1996, 23:384-391.
128. Katz BP, Blythe MJ, Van der Pol B, Jones
RB. Declining prevalence of chlamydial
infection among adolescent girls. Sex
Transm Dis 1996 May-Jun; 23(3):226-9.
129. Kaul R, Kimani J, Nagelkerke NJ, Fonck K,
Ngugi EN, Keli F, MacDonald KS, Maclean
IW, Bwayo JJ, Temmerman M, Ronald AR,
Moses S; Kibera HIV Study Group. Monthly
antibiotic chemoprophylaxis and incidence
of sexually transmitted infections
and HIV-1 infection in Kenyan sex workers:
a randomized controlled trial. JAMA
2004 Jun 2; 291(21):2555-62.
130. Kelly JA, Murphy DA, Washington CD et
al. The effects of HIV/AIDS intervention
groups for high-risk women in urban clinics.
American journal of public health
1994; 84(12):1918-22.
131. Khan MJ, Castle PE, Lorincz AT, Wacholder
S, Sherman M, Scott DR, Rush BB,
Glass AG, Schiffman M. The elevated 10-
year risk of cervical precancer and cancer
in women with human papillomavirus
(HPV) type 16 or 18 and the possible utility
of type-specific HPV testing in clinical
practice. J Natl Cancer Inst 2005 Jul 20;
97 (14):1072-9.
132. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness
of human papillomavirus DNA
testing in the United Kingdom, The Netherlands,
France, and Italy. J Natl Cancer
Inst 2005 Jun 15; 97(12):888-95.
133. Kinney W. HPV in primary screening: The
US experience. Invited Conference. 22nd
International Papillomavirus Conference
and Clinical Workshop 2005. CW-20.
134. Kiss H, Widhalm A, Geusau A, Husslein P.
Universal antenatal screening for syphilis:
is it still justified economically A 10-
year retrospective analysis. Eur J Obstet
Gynecol Reprod Biol 2004 Jan 15; 112(1):
24-8.
135. Koelen MA, Van der Ban AW. Health education
and health promotion. Wageningen
Academic Publishers.2004.
136. Kohl KS, Markowitz LE, Koumans EH. Developments
in the screening for Chlamydia
trachomatis: a review. Obstet Gynecol
Clin North Am 2003 Dec; 30(4):637-58.
137. Koutsky LA, Ault KA, Wheeler CM, Brown
DR, Barr E, Alvarez FB, Chiacchierini LM,
Jansen KU; Proof of Principle Study Investigators.
A controlled trial of a human
papillomavirus type 16 vaccine. N Engl J
Med 2002 Nov 21; 347(21):1645-51.
138. Kreiss J, Ngugi E, Holmes KK, Ndinya-
Achola J, Waiyaki P, Roberts PL, Ruminjo I,
Sajabi R, Kimata J, Fleming TR, Anzala A,
Holton D, Plummer F. Efficacy of nonoxynol-9
contraceptive sponge use in
preventing heterosexual acquisition
of HIV in Nairobi prostitutes. JAMA 1992;
268(4):477-482.
139. Kulasingam SL, Hughes JP, Kiviat NB, Mao
C, Weiss NS, Kuypers JM, Koutsky LA. Evaluation
of human papillomavirus testing
in primary screening for cervical abnormalities:
comparison of sensitivity, specificity,
and frequency of referral. JAMA
2002 Oct 9; 288(14):1749-57.
140. Laurian Y, Peynet J, Verroust F. HIV infection
in sexual partners of HIV-seropositive
patients with hemophilia. N Engl J
Med 1989 Jan 19; 320(3):183.
141. López de Munain J, Cámara MM, Santamaria
JM et al.Características clínico-epidemiológicas
de los nuevos diagnósticos
de infección por VIH. Med Clín (Barc)
2001:117:654-656.
142. López de Munain J, Santamaria JM, Cámara
MM, Zubero Z. Características clínico-epidemiológicas
de los pacientes recién
diagnosticados de infección por
VIH. Med Clín (Barc) 2002; 119(6):238-39.
143. Lowndes CM, Fenton KA; European Surveillance
of STI’s Network. Surveillance
systems for STIs in the European Union:
165